Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines: A Phase I Trial to Assess Safety and Immune Response.
Phase of Trial: Phase I
Latest Information Update: 15 Sep 2011
At a glance
- Drugs Tyrosinase DNA vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2011 Actual end date (September 2011) added as reported by ClinicalTrials.gov.
- 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.